Nicotinamide mononucleotide ("NMN", "NAMN", and "β-NMN") is a nucleotide derived from ribose and nicotinamide.

Market Analysis and Insights: Global and China β-Nicotinamide Mononucleotide (NMN) Market
This report focuses on global and China β-Nicotinamide Mononucleotide (NMN) market.
In 2020, the global β-Nicotinamide Mononucleotide (NMN) market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the β-Nicotinamide Mononucleotide (NMN) market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global β-Nicotinamide Mononucleotide (NMN) Scope and Market Size
β-Nicotinamide Mononucleotide (NMN) market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global β-Nicotinamide Mononucleotide (NMN) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the β-Nicotinamide Mononucleotide (NMN) market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Purity ＜98%
Purity ≥98%

Segment by Application
Health Care Products
Cosmetics
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
Bontac
Shandong Sihuan Pharmaceutical
EffePharm
Zhejiang Jiahua Pharmchemical